targeted therapies for dlbcl treatment
Published 4 years ago • 92 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
1:04
the potential of targeted therapy in dlbcl: open questions
-
1:43
the role of targeted therapies in the frontline treatment of mantle cell lymphoma
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
1:45
improving the frontline treatment of dlbcl
-
8:54
advances in extranodal natural killer/t-cell lymphoma
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
29:38
dlbcl treatment approaches: what you need to know
-
1:48
characterizing the development of mds in patients with cll in the era of targeted therapies
-
3:39
the role of novel therapies in r/r dlbcl
-
1:47
the potential clinical implications of targeted therapies for dlbcl and why the situation is complex
-
2:46
targeted therapies available for the treatment of patients with aml
-
2:26
feasibility of sequential treatment with cd19-targeted agents in patients with lbcl
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
2:04
salvage treatment options following car-t failure in dlbcl
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
4:57
sequencing of targeted therapies for cll
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks
-
2:38
car-t therapy for aggressive b-cell lymphomas